<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516"><gtr:id>0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516</gtr:id><gtr:name>University Hospital Southampton NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Trust Management Offices Mailpoint 18, Tremona Road</gtr:line1><gtr:city>Southampton</gtr:city><gtr:postCode>SO16 6YD</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Pathology</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516"><gtr:id>0719BE0D-CCE5-4FEA-BD59-08BFA7F0E516</gtr:id><gtr:name>University Hospital Southampton NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Trust Management Offices Mailpoint 18, Tremona Road</gtr:line1><gtr:city>Southampton</gtr:city><gtr:postCode>SO16 6YD</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/89064BFF-81AC-42C0-848E-E2CF54F99B11"><gtr:id>89064BFF-81AC-42C0-848E-E2CF54F99B11</gtr:id><gtr:firstName>Louise</gtr:firstName><gtr:surname>Robinson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CAFFB86F-3BEB-4EC4-9430-C6E9BB7CFD55"><gtr:id>CAFFB86F-3BEB-4EC4-9430-C6E9BB7CFD55</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>B</gtr:otherNames><gtr:surname>Wharton</gtr:surname><gtr:orcidId>0000-0003-2785-333X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5DFBC6B4-08F1-4E01-A41D-09B05254C01C"><gtr:id>5DFBC6B4-08F1-4E01-A41D-09B05254C01C</gtr:id><gtr:firstName>Cherie</gtr:firstName><gtr:otherNames>Frances</gtr:otherNames><gtr:surname>McCracken</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8B3CFE68-3C29-4317-BB27-F53F3AA2DF40"><gtr:id>8B3CFE68-3C29-4317-BB27-F53F3AA2DF40</gtr:id><gtr:firstName>Dominic</gtr:firstName><gtr:surname>Walsh</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6448E27D-50B3-4E01-89F5-8A3394ECE631"><gtr:id>6448E27D-50B3-4E01-89F5-8A3394ECE631</gtr:id><gtr:firstName>Antony</gtr:firstName><gtr:surname>Arthur</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/53196553-0949-4534-8A57-0627E996A16B"><gtr:id>53196553-0949-4534-8A57-0627E996A16B</gtr:id><gtr:firstName>Delphine</gtr:firstName><gtr:surname>Boche</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/09717709-C72F-4D1D-A890-7310F654D410"><gtr:id>09717709-C72F-4D1D-A890-7310F654D410</gtr:id><gtr:firstName>Carol</gtr:firstName><gtr:surname>Brayne</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6D96679F-7B87-4095-8643-EDEC89A16D03"><gtr:id>6D96679F-7B87-4095-8643-EDEC89A16D03</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Geoffrey</gtr:otherNames><gtr:surname>Ince</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3A23D8E4-F4BB-43C2-A277-A043CDF45E2D"><gtr:id>3A23D8E4-F4BB-43C2-A277-A043CDF45E2D</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:otherNames>Grant</gtr:otherNames><gtr:surname>McKeith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BA957A25-8096-4C62-919F-88819C7AE14F"><gtr:id>BA957A25-8096-4C62-919F-88819C7AE14F</gtr:id><gtr:firstName>Seth</gtr:firstName><gtr:surname>Love</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8924B01A-D106-41DD-8CE0-4578EF9DC1B0"><gtr:id>8924B01A-D106-41DD-8CE0-4578EF9DC1B0</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Bond</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/83FB2515-9680-4697-815B-398F03B71192"><gtr:id>83FB2515-9680-4697-815B-398F03B71192</gtr:id><gtr:firstName>Fiona</gtr:firstName><gtr:otherNames>Elaine</gtr:otherNames><gtr:surname>Matthews</gtr:surname><gtr:orcidId>0000-0002-1728-2388</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4BBE0A72-14A6-422B-8996-A499FB62F1F7"><gtr:id>4BBE0A72-14A6-422B-8996-A499FB62F1F7</gtr:id><gtr:firstName>James</gtr:firstName><gtr:surname>Nicoll</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900582"><gtr:id>B4A2DC6D-441A-46FE-9E6D-DC922147BE7C</gtr:id><gtr:title>Epidemiological neuropathology of dementia - The Cognitive Function and Ageing Neuropathology Study</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900582</gtr:grantReference><gtr:abstractText>Brain pathology is central to understanding dementia. For 18 years respondents in the MRC Cognitive Function and Ageing Study (CFAS), a major, prospective, longitudinal, population-based survey of mental health and frailty among older people, have donated their brains for research. The donor cohort has more than 500 completed brain examinations and provides an internationally acclaimed resource for research into the causes of dementia. In 2008 the MRC funded new clinical cohorts within CFAS (CFAS-II) to study how dementia has changed between those susceptible more than 20 years ago and today?s older people. Many changes in this period affecting lifestyles, health-care, nutrition and other factors raise the possibility that the pathology underlying dementia may evolve across generations. In an era when there is active development of innovative treatments to protect the brain and treat dementia we need as much information as possible about these changes with time. As the largest of only a handful of truly population-based studies of dementia in the world, and the only one with cross-generational cohorts, CFAS will uniquely be able to address these questions.
This study has two main objectives. One is to enrol a new cohort of potential donors from CFAS-II. The second is methodological, but of vital importance to the continuing relevance and future viability of brain pathology studies in CFAS. Until now the brains have been evaluated using a method developed 20 years ago (CERAD). There have been major scientific advances in the field of dementia across this time and the CERAD protocol does not capture a range of pathologies that are now considered to be very important. It is also very imprecise about what methods should be used to demonstrate the various pathologies. Recently colleagues in Europe have formed a consortium (BrainNet) which has resolved, through validation studies, the best way to look for and evaluate brain pathologies of relevance to dementia. 
We propose to re-evaluate the CFAS-I donor brains, using the BrainNet protocols, to generate a new ?state-of-the-art? data set. We will also capture biochemical data which is important but not a part of standard pathology methods. We will investigate the hypothesis that this more comprehensive picture of brain pathology will significantly improve our ability to distinguish demented from non-demented people based on pathology. The data will also be invaluable to our wide range of collaborators currently using tissue from the CFAS brain donor resource.</gtr:abstractText><gtr:technicalSummary>Dementia has come to be regarded as the product of distinct ?diseases? such as Alzheimer?s and Vascular Dementias. This paradigm derives from cohorts selected on the basis of clinical features and pathological examination at autopsy, an approach that has been validated over many years. There is no doubt that individual patients can be selected to conform to these diseases but recent work in population-based cohorts suggests that the clinical reality of dementia in the elderly is more complex. In comparison to population-based studies these selected cohort studies seriously underemphasise the prevalence of mixed pathologies and the impact of chronic vascular disease. Population-based studies are few in number (only 6 world-wide) and take many years to accumulate a cohort of brain donations with real statistical power. The MRC Cognitive Function and Ageing Study (CFAS) neuropathology study now has 525 brain donations from which we developed a new ?epidemiological neuropathology? approach to the relationship between cognition and brain pathology in older people. It is the largest, truly population-based, cohort in existence and is an essential resource in global research on dementia. 
 Two developments impact on this resource. Firstly there are major changes in the methodologies best suited to recognise and assign severity to brain lesions in older people. The pathology data are currently based on the CERAD protocol which is more than 17 years old. CERAD predates recognition of major pathological substrates (e.g. neuritic tau and synuclein, hippocampal sclerosis, TDP43) and does not provide a validated protocol for the assessment of important lesions like degenerative small vessel disease and amyloid angiopathy. Recent work within the EU Framework 6 BrainNet Europe consortium provides new, robust, validated approaches to the evaluation of Alzheimer-type and synuclein pathology based on modern immunocytochemical staining methods. Secondly the establishment of new CFAS cohorts in three centres (Cambridge, Newcastle upon Tyne, Nottingham) to investigate cohort effects in the epidemiology of dementia creates a unique opportunity to investigate changes the prevalence of pathological substrates arising from evolving socioeconomic factors. The proposed study will: 1) revaluate brain pathology in the CFAS1 donor cohort using validated, comprehensive measures, including biochemistry, to investigate hypotheses related to the role of pathology in cognitive decline and dementia, and for the numerous additional correlative studies ongoing in this cohort; 2) Establish a new donor cohort within CFAS2 to enable future inter-cohort comparison studies of the evolution of dementia substrates across time.</gtr:technicalSummary><gtr:fund><gtr:end>2015-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1597081</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Prof James Nicoll</gtr:description><gtr:id>EF008F3C-716E-42A1-AFF5-ACE3E8BC6358</gtr:id><gtr:impact>See all publications</gtr:impact><gtr:outcomeId>pihcsQ3Eo1q-2</gtr:outcomeId><gtr:partnerContribution>- Bring the human neuropathology expertise, essentiel to the work
- Co-applicant on other grants
- Co-supervisor Mariko Taga (ART-PhD2011-22)</gtr:partnerContribution><gtr:piContribution>- Involved in the clinico-neuropathological follow-up of the AD patients actively immunised against Abeta42 (AN1792).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neuropathology</gtr:department><gtr:description>Prof Seth Love</gtr:description><gtr:id>16B1148E-942F-4638-8935-7A8A857DDAED</gtr:id><gtr:impact>See publications</gtr:impact><gtr:outcomeId>EKK3L1e8UyX-1</gtr:outcomeId><gtr:partnerContribution>- Access to the South West Dementia Brain Bank
- Significant input into my research 
- Co-applicant on 3 grants.</gtr:partnerContribution><gtr:piContribution>- Access to the immunised AD cases</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Southampton University Hospitals NHS Trust (SUHT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cellular Pathology</gtr:department><gtr:description>Prof James Nicoll</gtr:description><gtr:id>C546D3AA-66C8-41C8-A524-7D328EAD7FBF</gtr:id><gtr:impact>See all publications</gtr:impact><gtr:outcomeId>pihcsQ3Eo1q-1</gtr:outcomeId><gtr:partnerContribution>- Bring the human neuropathology expertise, essentiel to the work
- Co-applicant on other grants
- Co-supervisor Mariko Taga (ART-PhD2011-22)</gtr:partnerContribution><gtr:piContribution>- Involved in the clinico-neuropathological follow-up of the AD patients actively immunised against Abeta42 (AN1792).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Neuroscience</gtr:department><gtr:description>Epidemiological neuropathology of dementia</gtr:description><gtr:id>AF488D80-A221-44B0-87B4-1C36EAC8BEC2</gtr:id><gtr:impact>This MRC CFAS consortium involves collaboration with Sheffield, Bristol and Cambridge.
2 papers in preparation</gtr:impact><gtr:outcomeId>YiV5j6wqryJ-1</gtr:outcomeId><gtr:partnerContribution>This project is funded by the MRC as a part of an MRC CFAS consortium &amp;quot;Epidemiological neuropathology of dementia - The Cognitive Function and Ageing Neuropathology Study&amp;quot; (G0900582).</gtr:partnerContribution><gtr:piContribution>We have been successful in obtaining funding to investigate microglial activation in the CFAS cohort. Using the CFAS cohort, we will investigate whether (i) microglial activation correlates with the presence of dementia and (ii) the role of APOE genotype on the risk of dementia. This project is funded by the MRC as a part of an MRC CFAS consortium &amp;quot;Epidemiological neuropathology of dementia - The Cognitive Function and Ageing Neuropathology Study&amp;quot; .</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Biostatistics Unit</gtr:department><gtr:description>Epidemiological neuropathology of dementia</gtr:description><gtr:id>1EE83D33-7940-4B9A-8734-930EE7FC4BF9</gtr:id><gtr:impact>This MRC CFAS consortium involves collaboration with Sheffield, Bristol and Cambridge.
2 papers in preparation</gtr:impact><gtr:outcomeId>YiV5j6wqryJ-4</gtr:outcomeId><gtr:partnerContribution>This project is funded by the MRC as a part of an MRC CFAS consortium &amp;quot;Epidemiological neuropathology of dementia - The Cognitive Function and Ageing Neuropathology Study&amp;quot; (G0900582).</gtr:partnerContribution><gtr:piContribution>We have been successful in obtaining funding to investigate microglial activation in the CFAS cohort. Using the CFAS cohort, we will investigate whether (i) microglial activation correlates with the presence of dementia and (ii) the role of APOE genotype on the risk of dementia. This project is funded by the MRC as a part of an MRC CFAS consortium &amp;quot;Epidemiological neuropathology of dementia - The Cognitive Function and Ageing Neuropathology Study&amp;quot; .</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Amyloidosis and Acute Phase Proteins</gtr:department><gtr:description>SAP in dementia - populatoin based study</gtr:description><gtr:id>81C103C9-5427-476B-B021-7765052C6033</gtr:id><gtr:impact>no outputs yet</gtr:impact><gtr:outcomeId>siD2P4ThQ1H-1</gtr:outcomeId><gtr:partnerContribution>The partners are international experts on the analysis of SAP content in tissues. they are using this expertise to provide quantitative data on the CFAS cohort</gtr:partnerContribution><gtr:piContribution>We have recruited this collaborative group to provide data on brain SAP content in relation to other pathological and biochemical markers of dementia in the CFAS population representative brain donor cohort. We have provided temporal cortical tissue samples for a analysis from ~150 brains</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Keele University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life Sciences</gtr:department><gtr:description>aluminium</gtr:description><gtr:id>190F6C21-A1F2-48AD-95CC-C64677D3981E</gtr:id><gtr:impact>peer reviewed publication in Metallomics. multidisciplinary - neuropathology, biostatistics, biometallic analysis, public health</gtr:impact><gtr:outcomeId>jRMBGaX835D-1</gtr:outcomeId><gtr:partnerContribution>elemental mass analysis</gtr:partnerContribution><gtr:piContribution>provision of population representative human tissue cohort for elemental mass analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Epidemiological neuropathology of dementia</gtr:description><gtr:id>3DCC0F21-4FFC-4A97-88ED-DCDA982CB2A5</gtr:id><gtr:impact>This MRC CFAS consortium involves collaboration with Sheffield, Bristol and Cambridge.
2 papers in preparation</gtr:impact><gtr:outcomeId>YiV5j6wqryJ-5</gtr:outcomeId><gtr:partnerContribution>This project is funded by the MRC as a part of an MRC CFAS consortium &amp;quot;Epidemiological neuropathology of dementia - The Cognitive Function and Ageing Neuropathology Study&amp;quot; (G0900582).</gtr:partnerContribution><gtr:piContribution>We have been successful in obtaining funding to investigate microglial activation in the CFAS cohort. Using the CFAS cohort, we will investigate whether (i) microglial activation correlates with the presence of dementia and (ii) the role of APOE genotype on the risk of dementia. This project is funded by the MRC as a part of an MRC CFAS consortium &amp;quot;Epidemiological neuropathology of dementia - The Cognitive Function and Ageing Neuropathology Study&amp;quot; .</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Epidemiological neuropathology of dementia</gtr:description><gtr:id>5B0E4417-B5D0-465A-AA74-33B4E1759376</gtr:id><gtr:impact>This MRC CFAS consortium involves collaboration with Sheffield, Bristol and Cambridge.
2 papers in preparation</gtr:impact><gtr:outcomeId>YiV5j6wqryJ-2</gtr:outcomeId><gtr:partnerContribution>This project is funded by the MRC as a part of an MRC CFAS consortium &amp;quot;Epidemiological neuropathology of dementia - The Cognitive Function and Ageing Neuropathology Study&amp;quot; (G0900582).</gtr:partnerContribution><gtr:piContribution>We have been successful in obtaining funding to investigate microglial activation in the CFAS cohort. Using the CFAS cohort, we will investigate whether (i) microglial activation correlates with the presence of dementia and (ii) the role of APOE genotype on the risk of dementia. This project is funded by the MRC as a part of an MRC CFAS consortium &amp;quot;Epidemiological neuropathology of dementia - The Cognitive Function and Ageing Neuropathology Study&amp;quot; .</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Epidemiological neuropathology of dementia</gtr:description><gtr:id>C1E24E8D-E252-4500-812F-951766AF455B</gtr:id><gtr:impact>This MRC CFAS consortium involves collaboration with Sheffield, Bristol and Cambridge.
2 papers in preparation</gtr:impact><gtr:outcomeId>YiV5j6wqryJ-3</gtr:outcomeId><gtr:partnerContribution>This project is funded by the MRC as a part of an MRC CFAS consortium &amp;quot;Epidemiological neuropathology of dementia - The Cognitive Function and Ageing Neuropathology Study&amp;quot; (G0900582).</gtr:partnerContribution><gtr:piContribution>We have been successful in obtaining funding to investigate microglial activation in the CFAS cohort. Using the CFAS cohort, we will investigate whether (i) microglial activation correlates with the presence of dementia and (ii) the role of APOE genotype on the risk of dementia. This project is funded by the MRC as a part of an MRC CFAS consortium &amp;quot;Epidemiological neuropathology of dementia - The Cognitive Function and Ageing Neuropathology Study&amp;quot; .</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Alzheimer's Research UK Public event</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>659A0179-976C-478E-A137-CDBA62D41E66</gtr:id><gtr:impact>The event included hands-on presentations by researchers who are using animal models of AD, as well as presentations by clinicians and academics within and outside the South Coast network. The interactive booths were particularly well received by the public.

Members of the public have requested to receive further information from upcoming events and the ARUK.</gtr:impact><gtr:outcomeId>AwbXUmfNpyc</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer's Society Network Volunteers Visit</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>401AC34F-16D3-4413-B871-DB8A59E01890</gtr:id><gtr:impact>Visit by lay group. Talks given on the various projects we have underway.</gtr:impact><gtr:outcomeId>58aeac6b4bc2a3.98213047</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>insitute open days</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8E309FDF-E62C-4749-9D3A-EDD0E2E5C717</gtr:id><gtr:impact>Up to 100 public attendees who were able to ask questions and then visit the laboratories to talk to the research team directly

Open day public feedback very positive. Attendees from dementia charities and support groups highly engaged locally</gtr:impact><gtr:outcomeId>K5pkWrutXgG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Journal promotion of one of our papers</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1CAE0766-00C1-4A6B-BB1C-83D93CB245D2</gtr:id><gtr:impact>Promotion of our article on neuronal DNA damage response associated signalling changes.. by the publisher, Wiley to coincide with National Alzheimer's Awareness month.</gtr:impact><gtr:outcomeId>58aead40751cc0.81593092</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog post</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>820C95DD-5534-4D36-8BC9-BF88DA7FE0CD</gtr:id><gtr:impact>Release of blog post about our Alz Soc funded diabetes grant, written by the post doc.</gtr:impact><gtr:outcomeId>58aeabe8998a79.81563903</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>84450</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Scholarship</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>57A64364-47EC-4280-84BE-520A193D3B68</gtr:id><gtr:outcomeId>58aea9b53cfbf1.37273855</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>225718</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Alzheimer?s Society</gtr:fundingOrg><gtr:id>1E37D960-887E-4CD2-85DB-40507801C357</gtr:id><gtr:outcomeId>58aea8206b9214.45801259</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>204615</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Junior Fellowships</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Alzheimer?s Society</gtr:fundingOrg><gtr:id>F4689E19-EB70-457C-93AB-7DA13EA70372</gtr:id><gtr:outcomeId>58aea8950eb826.72566344</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>316</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARUK major grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK-PG2012-8</gtr:fundingRef><gtr:id>4BF39242-93CB-41CB-A725-6BD043EDAE8F</gtr:id><gtr:outcomeId>56cde94a509de4.81089186</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>237984</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Interdisciplinary research grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>ED882216-0A6B-4167-AF61-4628B5FCA43E</gtr:id><gtr:outcomeId>58aea7729ca787.65390804</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>sensing-imaging-for-diagnosis-of-dementias</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/M006328/1</gtr:fundingRef><gtr:id>AAD3097B-5592-4844-A0D8-F04C3D04C796</gtr:id><gtr:outcomeId>54647fd235c7a6.28222139</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>369923</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0900582</gtr:fundingRef><gtr:id>91E824CC-09BA-4C40-9D56-D92F730AF585</gtr:id><gtr:outcomeId>062F7A52CC20</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>213317</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARUK Clinical Research Fellowship</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>DDED802E-B852-4DED-B6A6-1393B0699CE5</gtr:id><gtr:outcomeId>hXHDiyk63C5</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>87900</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARUK PhD Scholarship</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK PhD2016-1</gtr:fundingRef><gtr:id>D1C0DEB9-8727-43C2-860C-0988D8EE2A82</gtr:id><gtr:outcomeId>58aea9464a0e09.36002289</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Developmental Pathway Funding scheme</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F352FC25-CBE0-404C-AE4A-3928A513CD2D</gtr:id><gtr:outcomeId>Nksf5jef4UA</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>413000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J004308/1</gtr:fundingRef><gtr:id>71E1167F-C2E0-4712-9AA9-38CB78E92B73</gtr:id><gtr:outcomeId>JKaXepKpDD9</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Astrocyte transcriptome at low and high levels of Alzheimer's neuropathology.</gtr:description><gtr:id>58D5EAF5-788E-4A74-B616-10A01FD7DE00</gtr:id><gtr:impact>Transcriptome published on the GEO gene expression database - available to all researchers.
Gene Expression Omnibus Repository accession GSE2652</gtr:impact><gtr:outcomeId>JYtR9sBmUxP</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Astrocyte microarray transcriptome</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Gene expression data deposited in the Gene Expression Omnibus, accession number GSE66333</gtr:description><gtr:id>A866686E-FC68-47B5-AE8D-BC6B76D6D4C4</gtr:id><gtr:impact>Availability of data to bioinformatics community.</gtr:impact><gtr:outcomeId>58aeaf12282b15.95130344</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Gene expression microarray data associated with neuronal DNA damage</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>176DA992-FFD8-45C1-9A27-9A04445AF5A5</gtr:id><gtr:title>A reduced astrocyte response to ?-amyloid plaques in the ageing brain associates with cognitive impairment.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0932dcd014438629afa5aaa305271b53"><gtr:id>0932dcd014438629afa5aaa305271b53</gtr:id><gtr:otherNames>Mathur R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>57553a342efac1.87531814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFC4DC5F-0A39-4122-8E44-A77D4BB94090</gtr:id><gtr:title>Staging and natural history of cerebrovascular pathology in dementia.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfee0e14aa823c41a2b0fff8d6b8e08e"><gtr:id>dfee0e14aa823c41a2b0fff8d6b8e08e</gtr:id><gtr:otherNames>Deramecourt V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>doi_13490_31824e8e7f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D1BB15F-3E3E-4C2A-B11E-F0EB52D6710B</gtr:id><gtr:title>Consensus recommendations on pathologic changes in the hippocampus: a postmortem multicenter inter-rater study.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/484b49f7159b0cdeab64f675a5c75aa1"><gtr:id>484b49f7159b0cdeab64f675a5c75aa1</gtr:id><gtr:otherNames>Rauramaa T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>doi_13490_318292492a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF7B9090-8339-4481-A8F6-26C7D57E2ADD</gtr:id><gtr:title>Metaflammasome components in the human brain: a role in dementia with Alzheimer's pathology?</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/995d70af76b640f01c2dc8aae3034a74"><gtr:id>995d70af76b640f01c2dc8aae3034a74</gtr:id><gtr:otherNames>Taga M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>571f22a858d3c5.19525288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>513B797E-B96E-48F0-BD03-31687D43899B</gtr:id><gtr:title>Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8589a7315a7ba0fad1154b0030273cf"><gtr:id>c8589a7315a7ba0fad1154b0030273cf</gtr:id><gtr:otherNames>Kovacs GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>5a8a94558eea48.15467579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B37FC27-3D30-4D62-9C18-9497D2860FD9</gtr:id><gtr:title>HFE H63D, C282Y and AGTR1 A1166C polymorphisms and brain white matter lesions in the aging brain.</gtr:title><gtr:parentPublicationTitle>Journal of neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/407d2d3de0af96bbe826d7ba42d8e95e"><gtr:id>407d2d3de0af96bbe826d7ba42d8e95e</gtr:id><gtr:otherNames>Gebril OH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0167-7063</gtr:issn><gtr:outcomeId>pm_13490_20_21332426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55DD8568-AD77-4830-97A4-83478E69E811</gtr:id><gtr:title>Alzheimer and vascular neuropathological changes associated with different cognitive States in a non-demented sample.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/176cf7be55b87a88882897217d2f0bac"><gtr:id>176cf7be55b87a88882897217d2f0bac</gtr:id><gtr:otherNames>Stephan BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_13490_20_22233761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3ABC78B-C838-4E60-ACF5-0AFAFFC7E104</gtr:id><gtr:title>Brain iron dysregulation and the risk of ageing white matter lesions.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/407d2d3de0af96bbe826d7ba42d8e95e"><gtr:id>407d2d3de0af96bbe826d7ba42d8e95e</gtr:id><gtr:otherNames>Gebril OH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>pm_13490_20_21979376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81BA98D2-D875-4909-B096-06CA7EA39582</gtr:id><gtr:title>A reduced astrocyte response to ?-amyloid plaques in the ageing brain associates with cognitive impairment.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0932dcd014438629afa5aaa305271b53"><gtr:id>0932dcd014438629afa5aaa305271b53</gtr:id><gtr:otherNames>Mathur R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>57681bd10f28b8.04917678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FECA8ED8-F874-4027-805B-B3519F9ADD83</gtr:id><gtr:title>Education, the brain and dementia: neuroprotection or compensation?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3ba8db1c0982650e2eac4d8b3f89ff3"><gtr:id>f3ba8db1c0982650e2eac4d8b3f89ff3</gtr:id><gtr:otherNames>EClipSE Collaborative Members</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>doi_55f9859851356945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C283F0A8-5A4C-4FE5-A702-0F1D54DB53E2</gtr:id><gtr:title>Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8589a7315a7ba0fad1154b0030273cf"><gtr:id>c8589a7315a7ba0fad1154b0030273cf</gtr:id><gtr:otherNames>Kovacs GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>58aea2521bf980.49678456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC3DAF8E-7794-44C3-A466-154C191C017E</gtr:id><gtr:title>Mesial temporal astrocyte tau pathology in the MRC-CFAS ageing brain cohort.</gtr:title><gtr:parentPublicationTitle>Dementia and geriatric cognitive disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af01bcaabff4dfd4ac18896c34ef80bc"><gtr:id>af01bcaabff4dfd4ac18896c34ef80bc</gtr:id><gtr:otherNames>Lace G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1420-8008</gtr:issn><gtr:outcomeId>doi_13490__000341581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E77E40AA-0031-4EBB-A3BC-BCA83699099F</gtr:id><gtr:title>A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70857d7918bb70a4eda7d19cf01c73c0"><gtr:id>70857d7918bb70a4eda7d19cf01c73c0</gtr:id><gtr:otherNames>Matthews FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58aea352a837c6.74650619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6000BF70-12D6-4F84-BB36-400B98FE6072</gtr:id><gtr:title>Post-mortem analysis of neuroinflammatory changes in human Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a53dde92aa730ee6da09a9b4e62f94ae"><gtr:id>a53dde92aa730ee6da09a9b4e62f94ae</gtr:id><gtr:otherNames>Gomez-Nicola D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>555483516608e9.05105399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>801F9E6C-7F68-45D7-BEDD-95A26AB1D93F</gtr:id><gtr:title>Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff9861a37e6da193cfc1fb2aa8e788e"><gtr:id>9ff9861a37e6da193cfc1fb2aa8e788e</gtr:id><gtr:otherNames>Wharton SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56d55b9805d558.93137702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>323D0B0F-CD9A-4EAF-AA2B-CF6D0DEBE900</gtr:id><gtr:title>Microinfarcts in an older population-representative brain donor cohort (MRC CFAS): Prevalence, relation to dementia and mobility, and implications for the evaluation of cerebral Small Vessel Disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70991cc8007ace7c6e26447d12035e59"><gtr:id>70991cc8007ace7c6e26447d12035e59</gtr:id><gtr:otherNames>Ince PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>58aea4a42bf335.84225202</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A17A68B-B64A-428D-8AD1-BDF902EE6191</gtr:id><gtr:title>Innate immunity in Alzheimer's disease: the relevance of animal models?</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d91d59c27a696e5bb1c5c7b7721e04"><gtr:id>26d91d59c27a696e5bb1c5c7b7721e04</gtr:id><gtr:otherNames>Franco Bocanegra DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>5a2fd2c82b38a8.06971579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>724152C8-4989-4251-904F-E04D30889C89</gtr:id><gtr:title>Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd557a19ad80f4b45467d18ceaab3fe5"><gtr:id>bd557a19ad80f4b45467d18ceaab3fe5</gtr:id><gtr:otherNames>Simpson JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_13490_20_21705112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D6205BD-DC7E-42EB-A5C2-9D6975B56AF8</gtr:id><gtr:title>Neuropathological correlates of late-life depression in older people.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/289c33a0d4c9c11e2d06634469f384a7"><gtr:id>289c33a0d4c9c11e2d06634469f384a7</gtr:id><gtr:otherNames>Tsopelas C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>pm_13490_20_21282780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B166805-BF94-4F14-8717-3B695F8E8E1C</gtr:id><gtr:title>TREM2 expression in the human brain: a marker of monocyte recruitment?</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/084ba9ba8ab07493615a7ed3551670a6"><gtr:id>084ba9ba8ab07493615a7ed3551670a6</gtr:id><gtr:otherNames>Fahrenhold M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>5a2fd75e0663a5.40836917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DFA1DD7-598E-445B-9B63-F40EC6E4DACB</gtr:id><gtr:title>Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9874f0754fd5baf81e418cfb417cb67a"><gtr:id>9874f0754fd5baf81e418cfb417cb67a</gtr:id><gtr:otherNames>Barker R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>pm_16372_22_23532085</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0780DFA6-7EEE-40D0-9182-13077769AD81</gtr:id><gtr:title>The aqueous phase of Alzheimer's disease brain contains assemblies built from ~4 and ~7 kDa A? species.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fd7c1d1345bf2ce7a23bdb0686f5efd"><gtr:id>6fd7c1d1345bf2ce7a23bdb0686f5efd</gtr:id><gtr:otherNames>Mc Donald JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>585d58d5705d98.39293357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AFE0429-168F-438D-BDED-45CE379E7A38</gtr:id><gtr:title>Genome-wide association study of neocortical Lewy-related pathology.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7c17ed5c2cf001307b1ed15341ae8d2"><gtr:id>b7c17ed5c2cf001307b1ed15341ae8d2</gtr:id><gtr:otherNames>Peuralinna T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>56e98085d0bdf1.12734444</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0AA002C-6FD7-46E9-9852-22DDB6EE87A3</gtr:id><gtr:title>Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.</gtr:title><gtr:parentPublicationTitle>American journal of neurodegenerative disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ce6eeacfdcd5222747dab3fa256a93b"><gtr:id>1ce6eeacfdcd5222747dab3fa256a93b</gtr:id><gtr:otherNames>Love S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2165-591X</gtr:issn><gtr:outcomeId>546484a0f00cb7.28684369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE0F1E19-B6E5-4B60-9442-18FEEBC43170</gtr:id><gtr:title>The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fd7c1d1345bf2ce7a23bdb0686f5efd"><gtr:id>6fd7c1d1345bf2ce7a23bdb0686f5efd</gtr:id><gtr:otherNames>Mc Donald JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>fvNxoZFsLaJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF6A7BE9-6974-48B0-B1F3-F58770A3F289</gtr:id><gtr:title>Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors.</gtr:title><gtr:parentPublicationTitle>Molecular brain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c58c64d02a3edc3d0ae27f66455b7e2"><gtr:id>6c58c64d02a3edc3d0ae27f66455b7e2</gtr:id><gtr:otherNames>Garwood CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1756-6606</gtr:issn><gtr:outcomeId>56e98085b08300.79108836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BB43511-BB11-42A1-AB30-1DE948297569</gtr:id><gtr:title>Association between APOE genotype, neuropathology and dementia in the older population of England and Wales.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/156a13dcfea5033b8e4698c3901b6895"><gtr:id>156a13dcfea5033b8e4698c3901b6895</gtr:id><gtr:otherNames>Nicoll JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>ShRFdj7iV2t</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC5ACD13-A05F-4244-86BD-D046CB9F79C6</gtr:id><gtr:title>Microglial immunophenotype in dementia with Alzheimer's pathology.</gtr:title><gtr:parentPublicationTitle>Journal of neuroinflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb09b35c7a49b456cb771e9aaee61a1f"><gtr:id>bb09b35c7a49b456cb771e9aaee61a1f</gtr:id><gtr:otherNames>Minett T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-2094</gtr:issn><gtr:outcomeId>585d68445564f8.82775932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>706AF2AE-475C-4AF6-A68A-5F0621110D6D</gtr:id><gtr:title>Multiple biological pathways link cognitive lifestyle to protection from dementia.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edc19c7ac33a213e3cac6bcf42707978"><gtr:id>edc19c7ac33a213e3cac6bcf42707978</gtr:id><gtr:otherNames>Valenzuela MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_13490_20_22055015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEDF8FB5-B5F7-49B4-A70E-859D3A0BDDFB</gtr:id><gtr:title>Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c7ab308611896920e4aca79171d9514"><gtr:id>3c7ab308611896920e4aca79171d9514</gtr:id><gtr:otherNames>Janaway BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>doi_13490__nan_12062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A101D1D-5B7A-4CB7-8B2D-296AFE95217F</gtr:id><gtr:title>Neuronal DNA damage response-associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of Alzheimer-type pathology.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd557a19ad80f4b45467d18ceaab3fe5"><gtr:id>bd557a19ad80f4b45467d18ceaab3fe5</gtr:id><gtr:otherNames>Simpson JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>57553a345aaa44.56617921</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5889365A-DAFB-45FC-B887-1185817B4F05</gtr:id><gtr:title>Epidemiological neuropathology: the MRC Cognitive Function and Aging Study experience.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff9861a37e6da193cfc1fb2aa8e788e"><gtr:id>9ff9861a37e6da193cfc1fb2aa8e788e</gtr:id><gtr:otherNames>Wharton SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_13490_20_21422529</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>468E9196-6CC9-425C-A970-C14F0C8359AC</gtr:id><gtr:title>From molecule to clinic and community for neurodegeneration: research to bridge translational gaps.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91e46d80372fd59501b4eb05128f2b88"><gtr:id>91e46d80372fd59501b4eb05128f2b88</gtr:id><gtr:otherNames>Brayne C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_13490_20_22647264</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6B15391-7C10-4954-BA98-0F84DF1E7D69</gtr:id><gtr:title>Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e0a6b54e53a39c8c686adf737fd555c"><gtr:id>7e0a6b54e53a39c8c686adf737fd555c</gtr:id><gtr:otherNames>Stratmann K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>56d55b97cdd087.90590749</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900582</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>